Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2006
11/30/2006WO2006127587A1 Pyrrolopyridines useful as inhibitors of protein kinase
11/30/2006WO2006127368A2 Methods for synthesizing imidazotriazinones
11/30/2006WO2006127331A2 Conversion process for 2,3-benzodiazepine enantiomers
11/30/2006WO2006127287A2 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
11/30/2006WO2006126730A1 Bicyclic pyrimidine compounds and process for production thereof
11/30/2006WO2006126718A1 Pyrazolopyrimidine derivative
11/30/2006WO2006125958A1 2-phenyl substituted imidazol [4 , 5b] pyridine/ pyrazine and purine derivatives as glucokinase modulators
11/30/2006WO2006125812A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/30/2006WO2006125784A1 Tricyclic spiro derivatives as crth2 modulators
11/30/2006WO2006092428A3 2-substituted 7-amino-azolopyrimidine, a method for the production and use thereof for controlling pathogenic fungi and agents containing said compound
11/30/2006WO2006091646A3 Small molecule inhibitors of mdm2 and uses thereof
11/30/2006WO2006079112A3 Enantioselective synthesis of merrilactone a and its analogs
11/30/2006WO2006017409A3 1,3-disubstituted heteroaryl nmda/nr2b antagonists
11/30/2006US20060270863 Conversion of amorpha-4,11-diene to artemisinin and artemisinin precursors
11/30/2006US20060270849 Process for producing pyrimidin-4-one compound
11/30/2006US20060270848 Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of gonadotropin releasing hormone receptor
11/30/2006US20060270846 Synthons; nanomembranes
11/30/2006US20060270729 Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
11/30/2006US20060270696 1,3,8-triazaspiro(4,5)decane derivatives; antiinflammatory agent for treating rheumatoid arthritis, allergic, multiple sclerosis, autoimmune disease such as inflammatory bowel disease
11/30/2006US20060270690 N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto
11/30/2006US20060270689 Novel Fused Heterocycles and Uses Thereof
11/30/2006US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006US20060270678 Pyrrolopyridazine derivatives
11/30/2006US20060270663 tyrosine kinase inhibitors such as N-[4-(4-amino-8,9-dihydro-7H-pyrimido[4,5-b][1,4]diazepin-6-yl)phenyl]-N'-phenylurea, used for treating benign or neoplastic proliferative diseases and autoimmune diseases; antitumor agents
11/30/2006US20060270661 Pyrrolobenzodiazepines
11/30/2006US20060270659 Pyrazolopyrimidines as CRF receptor antagonists
11/30/2006US20060270613 2,3,4,5,6-Pentahydroxyhexylamide of 4-(4-{4-[3-[3-(4-fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylcarbamoyl}phenoxy)benzoic acid, for example; antilipemic agents; anticholesterol agents
11/30/2006US20060270047 comprising a mixture of a phosphorus porphyrin complex and clacium or magnesium chloride, supported by a silica gel, changes color according to changes in moisture
11/30/2006US20060269876 Novel compound and method for synthesizing the same, ink, ink cartridge, recording unit, ink-jet recording apparatus, recording method, liquid composition, pattern generating method, article, environmental history-detecting method
11/30/2006US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
11/30/2006CA2609508A1 Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
11/30/2006CA2609126A1 Pyrrolopyridines useful as inhibitors of protein kinase
11/30/2006CA2604165A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
11/30/2006CA2602965A1 Tricyclic spiro derivatives as crth2 modulators
11/29/2006EP1726590A1 Cycloalkanopyridine derivative
11/29/2006EP1725565A2 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3
11/29/2006EP1725564A1 M3 muscarinic acetylcholine receptor antagonists
11/29/2006EP1725563A2 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
11/29/2006EP1725562A1 Pyrrolopyrimidine derivatives
11/29/2006EP1725561A1 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
11/29/2006EP1725560A1 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
11/29/2006EP1725559A2 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said compounds
11/29/2006EP1725558A1 Method for preparing compounds comprising cucurbituril groups
11/29/2006EP1725557A1 6-(2-chloro-5-halophenyl)-triazolopyrimidine, method for production and use thereof for controlling fungal pests and agents comprising the same
11/29/2006EP1725554A1 Hiv integrase inhibitors
11/29/2006EP1725238A2 M 3 muscarinic acetylcholine receptor antagonists
11/29/2006EP1725236A1 Novel m3 muscarinic acetylcholine receptor antagonists
11/29/2006EP1725102A1 Hiv integrase inhibitors
11/29/2006EP1725101A1 2-pyridinyl [7-(substituted-pyridin-4-yl) pyrazolo[1,5-a] pyrimidin-3-yl] methanones
11/29/2006EP1648408A4 Azepine derivatives as pharmaceutical agents
11/29/2006CN1871240A Pyrrolopyrimidine thion derivatives
11/29/2006CN1871239A Modulation of beta-catenin/tcf-activated transcription
11/29/2006CN1871237A 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-IV inhibitors
11/29/2006CN1871235A Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
11/29/2006CN1871008A Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
11/29/2006CN1870991A Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
11/29/2006CN1870896A Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
11/29/2006CN1286838C Method for preparing 2-arylamino-6H-imidazo[1,2-b]-1,2,4-triazole-6-ketone and its sterilizing activity
11/29/2006CN1286837C Method for extracting vitamine B2
11/29/2006CN1286836C Novel diketopyrrolopyrrole pigments
11/29/2006CN1286810C 2-acyl indol derivatives and their use as anti-tumour agents
11/28/2006US7141669 Cannabiniod receptor ligands and uses thereof
11/28/2006US7141598 Imidazole derivatives, production method thereof and use thereof
11/28/2006US7141579 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
11/28/2006US7141578 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
11/28/2006US7141575 Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists
11/28/2006US7141571 Anticancer agents; inhibits tyrosine kinase activity of growth factor receptors; antiproliferative agents
11/28/2006US7141568 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/28/2006US7141563 Used for prophylaxis and therapy of central nervous system disorders, including obsessive-compulsive disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, panic disorder, migraine, sleep disorders
11/28/2006US7141561 Substituted diaryl heterocycles, process for their preparation and their use as medicaments
11/28/2006CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006CA2228044C Dibenzimidazole radioprotectors
11/28/2006CA2173582C Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
11/28/2006CA2137203C Protein kinase c inhibitors
11/28/2006CA2113603C Tricyclic condensed heterocyclic compounds, their production and use
11/23/2006WO2006125194A2 Piperazine derivatives and their uses as therapeutic agents
11/23/2006WO2006124902A2 Synthesis of salinosporamide a and analogues thereof
11/23/2006WO2006124581A2 Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (fsh-r) antagonists
11/23/2006WO2006124523A1 Pyrrolobenzodiazepines and heteroaryl, aryl and cycloalkylamino ketone derivatives as follicle stimulating hormone receptor -(fish-r) antagonists
11/23/2006WO2006123242A1 1, 2, 4 -triazole derivatives as vasopressin antagonists
11/23/2006WO2006123175A1 Preparation of famciclovir and other purine derivatives
11/23/2006WO2006123121A1 Histone deacetylase inhibitors
11/23/2006WO2006122740A2 7-amino-6-hetarylimidazolo[1,2-a]pyrimidine compounds and use thereof for controlling harmful fungi
11/23/2006WO2006089633A3 Spiroketal-substituted cyclic ketoenols
11/23/2006WO2006087306A3 Diazabicyclic aryl derivatives and their use as cholinergic ligands at the nicotinic acetylcholine receptors
11/23/2006WO2006074041A3 Anti-tumor compounds
11/23/2006WO2006044449A3 Cgrp receptor antagonists
11/23/2006US20060264624 Methods for synthesizing imidazotriazinones
11/23/2006US20060264622 Synthesis of protected pyrrolobenzodiazepines
11/23/2006US20060264493 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/23/2006US20060264472 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-a] IMIDAZOLE-3-SULFONIC ACID
11/23/2006US20060264457 Such as 3-(Aminomethyl)-6-((S)-1-(cyclopropylsulfonyl)pyrrolidin-3-yl)-4-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one hydrochloride; for treatment of diabetes
11/23/2006US20060264446 6-Halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests
11/23/2006US20060264441 N-[(1-azabicyclo[2.2.2]oct-2-yl)arylmethyl]-benzamide derivatives; psychological, behavioral, eating, sexual, sleep, nervous system, and/or neurodegenerative disorders; drug abuse, alcoholism, schizophrenia, psychoses, Parkinson*s disease, epilepsy; analgesics, antidepressants, anxiolytic agents
11/23/2006US20060264440 Pyrazoles and methods of making and using the same
11/23/2006US20060264438 Pyrrolotriazine compounds as kinase inhibitors
11/23/2006US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006US20060264427 DNA-PK inhibitors
11/23/2006US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics
11/23/2006US20060264421 Conversion process for 2,3-benzodiazepine enantiomers